Home / Indicator library / Biotechnology and Medical Care / NANG Kuang (1752) overview
NANG Kuang (1752) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for NANG Kuang, on one pageNANG Kuang (1752) snapshot, key figures
NANG Kuang (1752): where today sits in the past year
Current value against the 2025-09-17 to 2026-09-17 range, built from 243 frozen daily vintages.
NANG Kuang (1752): where today sits across the whole market
The same figures read against every other listed company on 2026-09-17, rather than against this ticker's own history.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→1752: common questions
What is 1752's P/E ratio?
1752 traded at a price-to-earnings ratio of 15.42x in the official-source snapshot dated 2026-09-17. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 1752's price-to-book ratio?
1752's price-to-book ratio was 1.31x on 2026-09-17, taken as-is from the official public source.
What is 1752's dividend yield?
1752's cash dividend yield was 5.11% on 2026-09-17. Historical dividend policy and gap-fill records are available on the same page.
How fast is 1752's revenue growing?
1752 reported 12.4% year-on-year monthly revenue growth for 2026-08, from the official monthly revenue filing.
Is 1752's price / earnings high or low right now?
1752's price / earnings is 15.42x, which is above its one-year median of 14.96x and sits at the 63rd percentile of the 13.80–16.60x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Is 1752's price / book high or low right now?
1752's price / book is 1.31x, which is below its one-year median of 1.47x and sits at the 2nd percentile of the 1.31–1.66x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
How does 1752's price / earnings compare with the rest of the Taiwan market?
1752's price / earnings of 15.42x is below the market median of 17.99x and sits at the 41st percentile of the 1,542 tickers carrying a valid reading that day — 911 of them read higher. This is the cross-section on a single frozen date, a different question from where the ticker sits against its own past year.
How does 1752's price / book compare with the rest of the Taiwan market?
1752's price / book of 1.31x is below the market median of 1.64x and sits at the 39th percentile of the 1,078 tickers carrying a valid reading that day — 659 of them read higher. This is the cross-section on a single frozen date, a different question from where the ticker sits against its own past year.
Other Biotechnology and Medical Care tickers
159 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.